π΅οΈ Iqvia Holdings Inc. ($IQV)
SEC insider & ownership activity, last 12 months Β· CIK 1478242 Β· every row links its SEC filing
Over the last 12 months insiders sold $21.5M with no open-market buying against it. Bousbib Ari sold $20.6M (OctβDec). 3 planned sales are pending, the largest $26.1M (Ari Bousbib). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) Β· 2 sellers, $21.5M (8 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Bousbib Ari | 0 | β | 7 | $20.6M | Dec 18, 2025 |
| Eric Sherbet | 0 | β | 1 | $879K | Oct 29, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Vanguard Capital Management | 7.5% | 13G | Apr 30, 2026 | filing β | |
| Harris Associates L P | 6.8% | 13G | Aug 14, 2025 | filing β | |
| Harris Associates, Inc. | 6.8% | 13G | Aug 14, 2025 | filing β |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Keriann Cherofsky | $137K | Jul 29, 2026 | filing β |
| Eric Sherbet | $1.2M | Jul 29, 2026 | filing β |
| Ari Bousbib | $26.1M | Jul 29, 2026 | filing β |
| Ari Bousbib | $8.1M | Dec 18, 2025 | filing β |
| Ari Bousbib | $12.5M | Oct 29, 2025 | filing β |
| Eric Sherbet | $879K | Oct 29, 2025 | filing β |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Jul 28, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Jul 28, 2026 | filing β |
| Material agreement (1.01) | Jun 11, 2026 | filing β |
| New financial obligation (2.03) | Jun 11, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Jun 11, 2026 | filing β |
| Other events (8.01) | Jun 4, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Jun 4, 2026 | filing β |
| Other events (8.01) | Jun 3, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Jun 3, 2026 | filing β |
| Other events (8.01) | May 7, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing β |
| Earnings (2.02) | May 5, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | May 5, 2026 | filing β |
| Officer/director changes (5.02) | Apr 23, 2026 | filing β |
| Shareholder vote (5.07) | Apr 23, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Apr 23, 2026 | filing β |
| Earnings (2.02) | Feb 5, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Feb 5, 2026 | filing β |
| Material agreement (1.01) | Dec 9, 2025 | filing β |
| New financial obligation (2.03) | Dec 9, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Dec 9, 2025 | filing β |
| Officer/director changes (5.02) | Nov 5, 2025 | filing β |
| Reg FD disclosure (7.01) | Nov 5, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Nov 5, 2025 | filing β |
| Earnings (2.02) | Oct 28, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Oct 28, 2025 | filing β |
| Officer/director changes (5.02) | Sep 2, 2025 | filing β |
| Reg FD disclosure (7.01) | Sep 2, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Sep 2, 2025 | filing β |